Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Meningitis, Cryptococcal: early-phase trial registry

A small indexed set (4 trials) with no open enrollment listed right now.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count

Meningitis, Cryptococcal: 4 US clinical trials tracked, none currently recruiting.

Meningitis, Cryptococcal is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Allergy and Infectious Diseases (NIAID), running 2 of these trials.

Enrollment posture brief

Registry condition meningitis-cryptococcal

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #4115 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Meningitis, Cryptococcal (th…0%
Open-enrollment share among volume-matched conditions near Meningitis, Cryptococcal

Meningitis, Cryptococcal has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Meningitis, Cryptococcal on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Meningitis, Cryptococcal is recruiting below its size-band peers.

    0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Meningitis, Cryptococcal records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Fluconazole Drug
4 trials
Flucytosine Drug
2 trials
Amphotericin B Drug
2 trials
Itraconazole Drug
1 trials
Dexamethasone Drug
1 trials

US sites by state

Facility locations filed on Meningitis, Cryptococcal trials. A trial with sites in several states counts in each.

New York 4 trials
Illinois 3 trials
Florida 3 trials
Ohio 2 trials
Missouri 2 trials
Massachusetts 2 trials
California 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Meningitis, Cryptococcal page

4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Meningitis, Cryptococcal condition card totals 4 registered trials; most-linked intervention Fluconazole; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.